Sixfold Bioscience Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
18
Sixfold Bioscience General Information
Description
Developer of a ribonucleic acid delivery platform designed to conduct cell and gene therapeutics. The company's platform utilizes nanoparticles to simultaneously deliver therapeutic, diagnostic and targeting molecules to diseased cells such as cancer cells, even those in the most inaccessible regions of the body, such as the brain, enabling medical professionals to offer treatment to their patients.
Contact Information
Website
www.sixfold.bioCorporate Office
- The Imperial College White City Incubator
- Translation And Innovation Hub
- London W12 0BZ
- England, United Kingdom
Corporate Office
- The Imperial College White City Incubator
- Translation And Innovation Hub
- London W12 0BZ
- England, United Kingdom
Sixfold Bioscience Timeline
Sixfold Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Accelerator/Incubator | 01-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 11. Grant | 01-Mar-2023 | Completed | Pre-Clinical Trials | |||
| 10. Accelerator/Incubator | 19-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 9. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 8. Seed Round | 02-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 01-Apr-2021 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Mar-2020 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 01-Oct-2019 | $80.4K | $120K | Completed | Pre-Clinical Trials | |
| 3. Seed Round | 01-Jan-2019 | $120K | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sixfold Bioscience Comparisons
Industry
Financing
Details
Sixfold Bioscience Competitors (50)
One of Sixfold Bioscience’s 50 competitors is WindMIL Therapeutics, a Venture Capital-Backed company based in Baltimore, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| WindMIL Therapeutics | Venture Capital-Backed | Baltimore, MD | ||||
| Akari Therapeutics | Formerly VC-backed | London, United Kingdom | ||||
| Carmine Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Triumvira | Venture Capital-Backed | Hamilton, Canada |
Sixfold Bioscience Patents
Sixfold Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026057749-A1 | Method and product | Pending | 11-Sep-2024 | ||
| EP-4594520-A2 | Compositions containing oligonucleotides with theranostic applications | Pending | 30-Sep-2022 | ||
| US-20260201363-A1 | Compositions containing oligonucleotides with theranostic applications | Pending | 30-Sep-2022 | ||
| WO-2024069235-A2 | Compositions containing oligonucleotides with theranostic applications | Inactive | 30-Sep-2022 | ||
| WO-2024069235-A3 | Compositions containing oligonucleotides with theranostic applications | Inactive | 30-Sep-2022 | C12Q1/6816 |
Sixfold Bioscience Signals
Sixfold Bioscience Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Grow London | Accelerator/Incubator | |||
| Biomedical Catalyst | Government | |||
| Coalition for Epidemic Preparedness Innovations | Impact Investing | Minority | ||
| Wellcome Leap | Not-For-Profit Venture Capital | Minority | ||
| Cantos Ventures | Venture Capital | Minority |
Sixfold Bioscience FAQs
-
When was Sixfold Bioscience founded?
Sixfold Bioscience was founded in 2017.
-
Where is Sixfold Bioscience headquartered?
Sixfold Bioscience is headquartered in London, United Kingdom.
-
What is the size of Sixfold Bioscience?
Sixfold Bioscience has 8 total employees.
-
What industry is Sixfold Bioscience in?
Sixfold Bioscience’s primary industry is Drug Delivery.
-
Is Sixfold Bioscience a private or public company?
Sixfold Bioscience is a Private company.
-
What is Sixfold Bioscience’s current revenue?
The current revenue for Sixfold Bioscience is .
-
How much funding has Sixfold Bioscience raised over time?
Sixfold Bioscience has raised $10.6M.
-
Who are Sixfold Bioscience’s investors?
Grow London, Biomedical Catalyst, Coalition for Epidemic Preparedness Innovations, Wellcome Leap, and Cantos Ventures are 5 of 18 investors who have invested in Sixfold Bioscience.
-
Who are Sixfold Bioscience’s competitors?
WindMIL Therapeutics, Akari Therapeutics, Carmine Therapeutics, Regenxbio, and Triumvira are some of the 50 competitors of Sixfold Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process